Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12931-017-0660-4.

Title:
Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition | Respiratory Research
Description:
Pulmonary fibrosis is a late manifestation of acute respiratory distress syndrome (ARDS). Sepsis is a major cause of ARDS, and its pathogenesis includes endotoxin-induced vascular injury. Recently, endothelial-to-mesenchymal transition (EndMT) was shown to play an important role in pulmonary fibrosis. On the other hand, dipeptidyl peptidase (DPP)-4 was reported to improve vascular dysfunction in an experimental sepsis model, although whether DPP-4 affects EndMT and fibrosis initiation during lipopolysaccharide (LPS)-induced lung injury is unclear. The aim of this study was to investigate the anti-EndMT effects of the DPP-4 inhibitor vildagliptin in pulmonary fibrosis after systemic endotoxemic injury. A septic lung injury model was established by intraperitoneal injection of lipopolysaccharide (LPS) in eight-week-old male mice (5 mg/kg for five consecutive days). The mice were then treated with vehicle or vildagliptin (intraperitoneally, 10 mg/kg, once daily for 14 consecutive days from 1 day before the first administration of LPS.). Flow cytometry, immunohistochemical staining, and quantitative polymerase chain reaction (qPCR) analysis was used to assess cell dynamics and EndMT function in lung samples from the mice. Lung tissue samples from treated mice revealed obvious inflammatory reactions and typical interstitial fibrosis 2 days and 28 days after LPS challenge. Quantitative flow cytometric analysis showed that the number of pulmonary vascular endothelial cells (PVECs) expressing alpha-smooth muscle actin (α-SMA) or S100 calcium-binding protein A4 (S100A4) increased 28 days after LPS challenge. Similar increases in expression were also confirmed by qPCR of mRNA from isolated PVECs. EndMT cells had higher proliferative activity and migration activity than mesenchymal cells. All of these changes were alleviated by intraperitoneal injection of vildagliptin. Interestingly, vildagliptin and linagliptin significantly attenuated EndMT in the absence of immune cells or GLP-1. Inhibiting DPP-4 signaling by vildagliptin could ameliorate pulmonary fibrosis by downregulating EndMT in systemic LPS-induced lung injury.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We see no obvious way the site makes money.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {🔍}

cells, pulmonary, fibrosis, vildagliptin, endmt, article, pubmed, lps, pvecs, dpp, google, scholar, cell, endothelial, lung, injury, cas, vascular, mice, significantly, systemic, transition, mesenchymal, days, administration, fig, expression, glp, model, attenuated, ros, study, increased, linagliptin, endothelialtomesenchymal, acute, reported, revealed, isolated, mouse, inhibitors, fcm, increase, inhibiting, inhibitor, treatment, analyses, hmvecls, central, lpsinduced,

Topics {✒️}

post-ali pulmonary fibrosis cd31−/cd45−/cd326− cells treated radiation-induced pulmonary fibrosis systemic endotoxin-induced ali lincrna-p21 induced inhibition hypoxia-induced vascular endothelial article download pdf lipopolysaccharide-induced lung injury bleomycin-induced pulmonary fibrosis lps-induced pulmonary fibrosis glp-1-independent antioxidant pathway streptozotocin-induced diabetic mice prominent pulmonary fibrosis endothelium-derived mesenchymal cells anti-cd31-pe/cy7 inhibited lps-induced endmt oral intake amount antioxidant pathway independent ameliorates endothelial dysfunction cd31+/cd45−/cd326− cells cd31−/cd45−/cd326− cells pi−/cd31+/cd45− cells pharmacological dpp4 inhibition transcription factor related respiratory epithelial injury inhibiting lps-induced endmt unique drug-specific effects α-sma+-gated pvecs quantitative rt-pcr analyses pulmonary fibrosis induced induced lung injury lps-treated mice compared cd31+/α-sma+-cells pulmonary fibrosis model acute lung injury rat renal interstitium α-sma+-hmvec-ls 144 wound healing assay dipeptidyl peptidase-4 inhibition full access lps-hmvec-ls treated lps-treated hmvec-ls pancreas β-cell privacy choices/manage cookies ameliorate kidney fibrosis cd26/dipeptidyl peptidase 4 5 mg dispase ii facscantotm ii instrument dipeptidyl peptidase-4 inhibitor hypoxia-induced apoptosis

Questions {❓}

  • Do incretins improve endothelial function?
  • Endothelial to mesenchymal transition (EndMT): an active process in chronic obstructive pulmonary disease (COPD)?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition
         description:Pulmonary fibrosis is a late manifestation of acute respiratory distress syndrome (ARDS). Sepsis is a major cause of ARDS, and its pathogenesis includes endotoxin-induced vascular injury. Recently, endothelial-to-mesenchymal transition (EndMT) was shown to play an important role in pulmonary fibrosis. On the other hand, dipeptidyl peptidase (DPP)-4 was reported to improve vascular dysfunction in an experimental sepsis model, although whether DPP-4 affects EndMT and fibrosis initiation during lipopolysaccharide (LPS)-induced lung injury is unclear. The aim of this study was to investigate the anti-EndMT effects of the DPP-4 inhibitor vildagliptin in pulmonary fibrosis after systemic endotoxemic injury. A septic lung injury model was established by intraperitoneal injection of lipopolysaccharide (LPS) in eight-week-old male mice (5 mg/kg for five consecutive days). The mice were then treated with vehicle or vildagliptin (intraperitoneally, 10 mg/kg, once daily for 14 consecutive days from 1 day before the first administration of LPS.). Flow cytometry, immunohistochemical staining, and quantitative polymerase chain reaction (qPCR) analysis was used to assess cell dynamics and EndMT function in lung samples from the mice. Lung tissue samples from treated mice revealed obvious inflammatory reactions and typical interstitial fibrosis 2 days and 28 days after LPS challenge. Quantitative flow cytometric analysis showed that the number of pulmonary vascular endothelial cells (PVECs) expressing alpha-smooth muscle actin (α-SMA) or S100 calcium-binding protein A4 (S100A4) increased 28 days after LPS challenge. Similar increases in expression were also confirmed by qPCR of mRNA from isolated PVECs. EndMT cells had higher proliferative activity and migration activity than mesenchymal cells. All of these changes were alleviated by intraperitoneal injection of vildagliptin. Interestingly, vildagliptin and linagliptin significantly attenuated EndMT in the absence of immune cells or GLP-1. Inhibiting DPP-4 signaling by vildagliptin could ameliorate pulmonary fibrosis by downregulating EndMT in systemic LPS-induced lung injury.
         datePublished:2017-10-16T00:00:00Z
         dateModified:2017-10-16T00:00:00Z
         pageStart:1
         pageEnd:11
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12931-017-0660-4
         keywords:
            Endothelial-to-mesenchymal transition
            Pulmonary fibrosis
            Dipeptidyl peptidase 4
            Post ARDS pulmonary fibrosis
            Pneumology/Respiratory System
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig6_HTML.gif
         isPartOf:
            name:Respiratory Research
            issn:
               1465-993X
            volumeNumber:18
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Toshio Suzuki
               url:http://orcid.org/0000-0002-0909-0466
               affiliation:
                     name:Vanderbilt University Medical Center
                     address:
                        name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
                        type:PostalAddress
                     type:Organization
                     name:Chiba University
                     address:
                        name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Yuji Tada
               affiliation:
                     name:Chiba University
                     address:
                        name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Santhi Gladson
               affiliation:
                     name:Vanderbilt University Medical Center
                     address:
                        name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rintaro Nishimura
               affiliation:
                     name:Chiba University
                     address:
                        name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                        type:PostalAddress
                     type:Organization
                     name:Chiba University
                     address:
                        name:Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Iwao Shimomura
               affiliation:
                     name:Chiba University
                     address:
                        name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Satoshi Karasawa
               affiliation:
                     name:Chiba University
                     address:
                        name:Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Koichiro Tatsumi
               affiliation:
                     name:Chiba University
                     address:
                        name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:James West
               affiliation:
                     name:Vanderbilt University Medical Center
                     address:
                        name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition
      description:Pulmonary fibrosis is a late manifestation of acute respiratory distress syndrome (ARDS). Sepsis is a major cause of ARDS, and its pathogenesis includes endotoxin-induced vascular injury. Recently, endothelial-to-mesenchymal transition (EndMT) was shown to play an important role in pulmonary fibrosis. On the other hand, dipeptidyl peptidase (DPP)-4 was reported to improve vascular dysfunction in an experimental sepsis model, although whether DPP-4 affects EndMT and fibrosis initiation during lipopolysaccharide (LPS)-induced lung injury is unclear. The aim of this study was to investigate the anti-EndMT effects of the DPP-4 inhibitor vildagliptin in pulmonary fibrosis after systemic endotoxemic injury. A septic lung injury model was established by intraperitoneal injection of lipopolysaccharide (LPS) in eight-week-old male mice (5 mg/kg for five consecutive days). The mice were then treated with vehicle or vildagliptin (intraperitoneally, 10 mg/kg, once daily for 14 consecutive days from 1 day before the first administration of LPS.). Flow cytometry, immunohistochemical staining, and quantitative polymerase chain reaction (qPCR) analysis was used to assess cell dynamics and EndMT function in lung samples from the mice. Lung tissue samples from treated mice revealed obvious inflammatory reactions and typical interstitial fibrosis 2 days and 28 days after LPS challenge. Quantitative flow cytometric analysis showed that the number of pulmonary vascular endothelial cells (PVECs) expressing alpha-smooth muscle actin (α-SMA) or S100 calcium-binding protein A4 (S100A4) increased 28 days after LPS challenge. Similar increases in expression were also confirmed by qPCR of mRNA from isolated PVECs. EndMT cells had higher proliferative activity and migration activity than mesenchymal cells. All of these changes were alleviated by intraperitoneal injection of vildagliptin. Interestingly, vildagliptin and linagliptin significantly attenuated EndMT in the absence of immune cells or GLP-1. Inhibiting DPP-4 signaling by vildagliptin could ameliorate pulmonary fibrosis by downregulating EndMT in systemic LPS-induced lung injury.
      datePublished:2017-10-16T00:00:00Z
      dateModified:2017-10-16T00:00:00Z
      pageStart:1
      pageEnd:11
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12931-017-0660-4
      keywords:
         Endothelial-to-mesenchymal transition
         Pulmonary fibrosis
         Dipeptidyl peptidase 4
         Post ARDS pulmonary fibrosis
         Pneumology/Respiratory System
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12931-017-0660-4/MediaObjects/12931_2017_660_Fig6_HTML.gif
      isPartOf:
         name:Respiratory Research
         issn:
            1465-993X
         volumeNumber:18
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Toshio Suzuki
            url:http://orcid.org/0000-0002-0909-0466
            affiliation:
                  name:Vanderbilt University Medical Center
                  address:
                     name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
                     type:PostalAddress
                  type:Organization
                  name:Chiba University
                  address:
                     name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Yuji Tada
            affiliation:
                  name:Chiba University
                  address:
                     name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Santhi Gladson
            affiliation:
                  name:Vanderbilt University Medical Center
                  address:
                     name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rintaro Nishimura
            affiliation:
                  name:Chiba University
                  address:
                     name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                     type:PostalAddress
                  type:Organization
                  name:Chiba University
                  address:
                     name:Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Iwao Shimomura
            affiliation:
                  name:Chiba University
                  address:
                     name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Satoshi Karasawa
            affiliation:
                  name:Chiba University
                  address:
                     name:Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Koichiro Tatsumi
            affiliation:
                  name:Chiba University
                  address:
                     name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:James West
            affiliation:
                  name:Vanderbilt University Medical Center
                  address:
                     name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Respiratory Research
      issn:
         1465-993X
      volumeNumber:18
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Vanderbilt University Medical Center
      address:
         name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
         type:PostalAddress
      name:Chiba University
      address:
         name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
         type:PostalAddress
      name:Chiba University
      address:
         name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
         type:PostalAddress
      name:Vanderbilt University Medical Center
      address:
         name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
         type:PostalAddress
      name:Chiba University
      address:
         name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
         type:PostalAddress
      name:Chiba University
      address:
         name:Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Chiba, Japan
         type:PostalAddress
      name:Chiba University
      address:
         name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
         type:PostalAddress
      name:Chiba University
      address:
         name:Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
         type:PostalAddress
      name:Chiba University
      address:
         name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
         type:PostalAddress
      name:Vanderbilt University Medical Center
      address:
         name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Toshio Suzuki
      url:http://orcid.org/0000-0002-0909-0466
      affiliation:
            name:Vanderbilt University Medical Center
            address:
               name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
               type:PostalAddress
            type:Organization
            name:Chiba University
            address:
               name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Yuji Tada
      affiliation:
            name:Chiba University
            address:
               name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:Santhi Gladson
      affiliation:
            name:Vanderbilt University Medical Center
            address:
               name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
               type:PostalAddress
            type:Organization
      name:Rintaro Nishimura
      affiliation:
            name:Chiba University
            address:
               name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
               type:PostalAddress
            type:Organization
            name:Chiba University
            address:
               name:Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:Iwao Shimomura
      affiliation:
            name:Chiba University
            address:
               name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:Satoshi Karasawa
      affiliation:
            name:Chiba University
            address:
               name:Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:Koichiro Tatsumi
      affiliation:
            name:Chiba University
            address:
               name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
               type:PostalAddress
            type:Organization
      name:James West
      affiliation:
            name:Vanderbilt University Medical Center
            address:
               name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
      name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
      name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
      name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA
      name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
      name:Department of Advanced Medicine in Pulmonary Hypertension, Graduate School of Medicine, Chiba University, Chiba, Japan
      name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
      name:Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
      name:Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan
      name:Department of Medicine, Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, USA

External Links {🔗}(173)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.93s.